EGFLAM-AS2

Across TCGA pan-cancer cohorts, EGFLAM-AS2 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated EGFLAM-AS2 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher EGFLAM-AS2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated EGFLAM-AS2 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

ACC, LIHC, and OV are the cancer types where EGFLAM-AS2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.114	0.772	<.001	108	view →
LIHC	OS	Tertile	II,III,IV	0.210	0.636	.009	72	view →
OV	DFS	Tertile	II,III,IV	0.459	0.563	.009	54	view →
READ	OS	Tertile	All	0.224	0.669	.002	39	view →
BLCA	DFS	Tertile	All	0.482	0.629	.004	36	view →
STAD	OS	Tertile	III,IV	0.235	0.563	<.001	36	view →
UCS	OS	Tertile	II,III,IV	0.361	0.663	.026	36	view →
UCEC	DFS	Tertile	All	0.833	0.907	.010	36	view →
MESO	OS	Tertile	III,IV	0.424	0.624	.009	18	view →
LUAD	DFS	Tertile	IV	0.223	0.710	.043	18	view →
ESCA	OS	Quartile	III,IV	0.835	0.481	.003	15	view →
KIRC	OS	Tertile	All	0.484	0.649	.041	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

EGFLAM-AS2–ACC (DFS)

Open the ACC breakdown →